An analysis performed by Lin and colleagues revealed that somatic mutations in the TRPM2 gene exhibit a negative correlation with pancreatic cancer patient survival rates in comparison to the group without TRPM2 mutations. This evidence concerns the gene TRPM2 and familial pancreatic carcinoma.